No Data
No Data
Express News | Science and Technology Innovation Board Review: The Science and Technology Innovation 50 Index closed down 1.42%, and the software sector sentiment is sluggish
Some Shareholders Feeling Restless Over APT Medical Inc.'s (SHSE:688617) P/E Ratio
APT Medical Inc.'s (SHSE:688617) price-to-earnings (or "P/E") ratio of 60.3x might make it look like a strong sell right now compared to the market in China, where around half of the companies have P/
Huitai Healthcare (688617): Continued improvement of brand capabilities, steady growth of electrophysiological products
Incident: The company released its first quarterly report of 2024, with operating income of 455 million yuan, up 30.20% year on year; net profit to mother of 140 million yuan, up 36.48% year on year; deducted non-net profit of 137 million yuan, up year on year
Mindray Healthcare (300760.SZ) obtains control of Huitai Healthcare
Mindray Healthcare (300760.SZ) announced that as of the date of this announcement, Cheng Zhenghui held 12.5193 million shares of Huitai Healthcare, accounting for 18.72% of Huitai Healthcare's total share capital, and 8.72% of the voting rights. The company held a total of 16.455,600 shares of Huitai Healthcare through Shenmai Holdings and its co-operator, Zhuhai Tongsheng, accounting for 24.61% of Huitai Healthcare's total share capital, and 24.61% of voting rights. The restructuring of the 2nd board of directors and supervisory board of directors of Huitai Medical has been completed, and the company has obtained control of Huitai Medical.
Huitai Healthcare (688617): Performance surpassed expectations and the cardiovascular leader gradually took shape
2023&1Q24 profit exceeded our expectations The company announced 2023&1Q24 results. Revenue in 2023 was 1.65 billion yuan, +36% year-on-year; attributable to mother/deducted non-net profit was 5.34/4, respectively.
Huitai Healthcare (688617): Steady operation and accelerated release of profits
Key investment events: The first quarter of 2024 achieved revenue of 455 million yuan (+30.20%, indicating year-on-year growth rate, same below), net profit of 140 million yuan (+36.48%), net profit of non-return to mother of 1.37 million yuan
No Data